Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
27.52
+0.48 (1.78%)
At close: May 5, 2026, 4:00 PM EDT
27.95
+0.43 (1.56%)
After-hours: May 5, 2026, 7:11 PM EDT

Genmab Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-1,3802,2011,4241,370
Short-Term Investments
-1,5741,9651,7891,588
Cash & Short-Term Investments
-2,9544,1663,2132,957
Cash Growth
--29.09%29.65%8.65%12.04%
Accounts Receivable
-930741.65829.05519.03
Other Receivables
-14-26.24.74
Total Trade Receivables
-944741.65855.25523.77
Inventory
-98.44--
Total Current Assets
-3,9004,9074,0613,477
Net Property, Plant & Equipment
-265242.97190.28149.1
Other Intangible Assets
-1,72814.9521.0138.84
Goodwill
-355---
Long-Term Investments
-3219.8419.1456.74
Other Long-Term Assets
-12731.3936.2740.37
Total Assets
-6,4145,2254,3353,766
Accrued Expenses
-494346.76248.57228.32
Current Portion of Long-Term Debt
273----
Current Portion of Leases
-1313.3310.659.48
Unearned Revenue
-375.9673.8478.45
Other Current Liabilities
-2398--
Total Current Liabilities
273744367.79262.39239.79
Long-Term Debt
5,001----
Long-Term Leases
-131100.6875.2855.51
Other Long-Term Liabilities
95397---
Total Long-Term Liabilities
5,096533176.94145.95131.98
Total Liabilities
5,3691,277544.72408.34371.76
Common Stock
-109.779.510.09
Additional Paid-in Capital
-1,9611,8451,7721,840
Accumulated Other Comprehensive Income
--2268.8814.1112.39
Retained Earnings
-3,3922,8172,1321,532
Shareholders' Equity
-5,1374,6803,9273,394
Total Liabilities & Equity
5,3696,4145,2254,3353,766
Total Debt
5,274144114.0185.9364.99
Net Cash (Debt)
-5,2742,8104,0523,1272,892
Net Cash Growth
--30.65%29.56%8.12%11.80%
Net Cash Per Share
-8.414.356.154.744.38
Book Value
05,1374,6803,9273,394
Book Value Per Share
-7.957.105.955.14
Tangible Book Value
03,0544,6653,9063,356
Tangible Book Value Per Share
-4.727.085.925.08
Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q